Abnormalities of hemostasis and abnormal uterine bleeding

Clinical Obstetrics and Gynecology

Volumn 48, Issue 2, 2005, Pages 284-294

  Siegel, Jamie E ^a,b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOCAPROIC ACID; ANTIFIBRINOLYTIC AGENT; ANTITHROMBIN; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; DESMOPRESSIN ACETATE; GESTAGEN; LEVONORGESTREL; MEFENAMIC ACID; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN SYNTHASE INHIBITOR; PROTEIN C; PROTEIN S; PROTHROMBIN; TRANEXAMIC ACID; VON WILLEBRAND FACTOR;

BLEEDING DISORDER; BLEEDING TIME; BLOOD CLOTTING DISORDER; BLOOD CLOTTING FACTOR 5 DEFICIENCY; BLOOD CLOTTING FACTOR 7 DEFICIENCY; BLOOD CLOTTING PARAMETERS; DISEASE ASSOCIATION; EDEMA; FEMALE; GASTROINTESTINAL SYMPTOM; HEADACHE; HEMOPHILIA A; HEMOPHILIA B; HEMOSTASIS; HOT FLUSH; HUMAN; HYPONATREMIA; MENORRHAGIA; NAUSEA; PARTIAL THROMBOPLASTIN TIME; PROTHROMBIN TIME; REVIEW; SIDE EFFECT; THROMBOCYTE AGGLUTINATION; THROMBOCYTE DYSFUNCTION; THROMBOCYTE RICH PLASMA; THROMBOSIS; UTERUS BLEEDING; VOMITING; VON WILLEBRAND DISEASE;

BLOOD COAGULATION DISORDERS; FEMALE; HEMOSTASIS; HUMANS; LABORATORY TECHNIQUES AND PROCEDURES; MENORRHAGIA; UTERINE HEMORRHAGE;

EID: 18044375783     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.grf.0000159536.81479.8c     Document Type: Review

References (36)

1. Quick AJ. Menstruation in hereditary bleeding disorders. Obstet Gynecol. 1966;28: 37-48.
2. Edlund M, Blomback M, von Schoultz B, et al. On the value of menorrhagia as a predictor for coagulation disorders. Am J Hematol. 1996;53:234-238.
3. Dirckx JH. Armand J. Quick: pioneer and prophet of coagulation research. Ann Intern Med. 1980;92:553-558.
4. Lethaby A, Farquhar C. Treatment for heavy menstrual bleeding. Br Med J. 2003;327: 1243-1244.
5. Fraser IS, McCarron G, Markham R. A preliminary study of factors influencing perception of menstrual blood loss volume. Am J Obstet Gynecol. 1984;149:788-793.
6. Hallberg L, Hogdahl AM, Nilsson L, et al. Menstrual blood loss-a population study. Acta Obstet Gynecol Scand. 1996;45:320-351.
7. Higham JM, O'Brien PMS, Shaw RW. Assessment of menstrual blood loss using a pictorial chart. Br J Obstet Gynaecol. 1990; 97:734-739.
8. Janssen CA, Scholten PC, Heintz APM. A simple visual assessment technique to discriminate between menorrhagia and normal menstrual blood loss. Obstet Gynecol. 1995;85:977-982.
9. Reid PC, Coker A, Coltart R. Assessment of menstrual blood loss using a pictorial chart: a validation study. Br J Obstet Gynaecol. 2000;107:320-322.
10. Sadler JE. Von Willebrand disease type 1: a diagnosis in search of a disease. Blood. 2003;101:2089-2093.
11. Rodeghiero F, Castaman G, Dini E. Epidemiological investigation of the prevalence of von Willebrand's disease. Blood. 1987; 69:454-459.
12. Shankar M, Lee CA, Sabin CA, et al. von Willebrand disease in women with menorrhagia: a systematic review. BJOG. 2004; 111:734-740.
13. Miller CH, Dilley A, Richardson L, et al. Population differences in von Willebrand factor levels affect the diagnosis of von Willebrand disease in African-American women. Am J Hematol. 2001;67:125-129.
14. Miller CH, Haff E, Platt SJ, et al. Measurement of von Willebrand factor activity: relative effects of ABO blood type and race. J Thromb Haemost. 2003;1:2191-2197.
15. Kirtava A, Drews C, Lally C, et al. Medical, reproductive and psychosocial experiences of women diagnosed with von Willebrand's disease receiving care in haemophilia treatment centres: a case-control study. Haemophilia. 2003;9:292-297.
16. Miller CH, Dilley A, Drews C. Changes in von Willebrand factor and factor VIII levels during the menstrual cycle. Thromb Haemost. 2002;87:1082-1083.
17. Sadler JE. Slippery criteria for von Willebrand disease type 1. J Thromb Haemost. 2004;2:1720-1723.
18. Sadler JE. A revised classification of von Willebrand Disease. For the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost. 1994;71: 520-525.
19. Refaai MA, Laposata M. Platelet aggregation. Platelets. 2002;291-296.
20. Woulfe D, Yang J, Prevost N, et al. Signal transduction during the initiation, extension, and perpetuation of platelet plug formation. Platelets. 2002;197-213.
21. Mannucci PM, Duga S, Peyvandi F. Recessively inherited coagulation disorders. Blood. 2004;104:1243-1252.
22. Bolton-Maggs PHB, Perry DJ, Chalmers EA, et al. The rare coagulation disorders-review with guidelines for management from the United Kingdom Haemophilia Centre Doctors' Organisation. Haemophilia. 2004; 10:593-628.
23. Amsterdam A, Jakubowski A, Castro-Malaspina H, et al. Management of menorrhagia: treatment of menorrhagia in women undergoing hematopoietic stem cell transplantation. Bone Marrow Transplant. 2004; 34:363-366.
24. Sramek A, Eikenboom JC, Briet E, et al. Usefulness of patient interview in bleeding disorders. Arch Intern Med. 1995;155: 1409-1415.
25. James A, Lukes A, Brancazio L, et al. Use of a new platelet function analyzer to detect von Willebrand disease in women with menorrhagia. Am J Obstet Gynecol 2004;191:449-455.
26. Kadir RA, Economides DL, Sabin CA. Frequency of inherited bleeding disorders in women with menorrhagia. Lancet. 1998; 351:485-489.
27. Dilley A, Drews C, Miller C. von Willebrand disease and other inherited bleeding disorders in women with diagnosed menorrhagia. Obstet Gynecol. 2001;97:630-636.
28. Saxena R, Gupta M, Gupta PK, et al. Inherited bleeding disorders in Indian women with menorrhagia. Haemophilia. 2003;9: 193-196.
29. Philipp CS, Dilley A, Miller CH, et al. Platelet functional defects in women with unexplained menorrhagia. J Thromb Haemost. 2003;1:477-484.
30. Kadir RA, Economides DL, Sabin CA, et al. Assessment of menstrual blood loss and gynaecological problems in patients with inherited bleeding disorders. Haemophilia. 1999;5:40-48.
31. James A, Matchar DB, Myers ER. Testing for von Willebrand disease in women with menorrhagia: a systematic review. Obstet Gynecol. 2004;104:381-388.
32. American College of Obstetricians and Gynecologists. von Willebrand's disease in gynecologic practice. ACOG committee opinion no. 263. Obstet Gynecol. 2001;98: 1185-1186.
33. Berntorp E, Follrud C, Lethagen S. No increased risk of venous thrombosis in women taking tranexamic acid. Thromb Haemost. 2001;86:714-715.
34. Wellington K, Wagstaff AJ. Tranexamic acid: a review of its use in the management of menorrhagia. Drugs. 2003;63:1417-1433.
35. Pitkin RM, Scott JR. Evaluating gynecological surgical procedures: trials and tribulations. JAMA. 2004;291:1503-1504.
36. Siegel JE, Kouides PA. Menorrhagia from a haematologist's point of view, part II: management. Haemophilia. 2002;8:1-9.